Metabolix (MBLX)

Add to Watchlists
Create an Alert
0.3705 -0.14  -27.35% NASDAQ Dec 9, 20:00 Delayed 2m USD

Metabolix Research and Development Expense (Quarterly):

1.57M for Sept. 30, 2016
View 4,000+ financial data types
View Full Chart

Metabolix Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Metabolix Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2004. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2016 1.57M
June 30, 2016 4.289M
March 31, 2016 4.332M
Dec. 31, 2015 4.24M
Sept. 30, 2015 4.088M
June 30, 2015 4.319M
March 31, 2015 3.925M
Dec. 31, 2014 4.062M
Sept. 30, 2014 4.088M
June 30, 2014 4.38M
March 31, 2014 4.812M
Dec. 31, 2013 4.603M
Sept. 30, 2013 4.515M
June 30, 2013 4.945M
March 31, 2013 4.859M
Dec. 31, 2012 7.195M
Sept. 30, 2012 4.931M
June 30, 2012 5.006M
March 31, 2012 6.045M
Dec. 31, 2011 6.093M
Sept. 30, 2011 6.153M
June 30, 2011 6.00M
March 31, 2011
Dec. 31, 2010
Sept. 30, 2010
June 30, 2010
March 31, 2010
Dec. 31, 2009
Sept. 30, 2009
June 30, 2009
March 31, 2009
Dec. 31, 2008
Sept. 30, 2008 6.571M
June 30, 2008 6.008M
March 31, 2008 5.934M
Dec. 31, 2007 5.373M
Sept. 30, 2007 5.695M
June 30, 2007 5.026M
March 31, 2007 3.808M
Dec. 31, 2006 3.723M
Sept. 30, 2006 2.842M
June 30, 2006 2.537M
March 31, 2006 2.132M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


MBLX Research and Development Expense (Quarterly) Benchmarks

Koppers Holdings
Senomyx 5.24M
Hybrid Coating Tech

MBLX Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.570M Sep 2016
Maximum 7.195M Dec 2012
Average 4.615M

MBLX Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("MBLX", "r_and_d_expense")
  • Last 5 data points: =YCS("MBLX", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.